e-drug
[Top] [All Lists]

[e-drug] USAID: Medicines Quality Assurance Systems Strengthening - Request for Information

E-DRUG: USAID: Medicines Quality Assurance Systems Strengthening - Request for 
Information 
--------------------------------------------------------------------------------------------------

Due Jun 20, 2018 5:00 pm EDT US

Dear Colleagues,

The U.S. Agency for International Development (USAID) is conducting market
research on the capability of organizations to provide services in the area
of medicines quality assurance systems strengthening in Low-and
Middle-Income Countries  (LMICs), including support for local
manufacturing. To participate in this Request for Information (RFI), please
forward a Capability Statement detailing your organization's breadth of
technical experience and geographic scope working in the areas specified in
the posting, including in LMICs as described in the RFI, accessible at:

FBO.gov:
https://www.fbo.gov/spg/AID/OM/MOZ/RFI-AID-GH-18-MQASSP/listing.html

and

Grants.gov:
https://www.grants.gov/web/grants/view-opportunity.html?oppId=306011

Please note that responding to this RFI will not give any advantage to any
organization or individual in any subsequently issued Notice of Funding
Opportunity/Request for Proposals, as responses are strictly for
information gathering purposes. Therefore, responding to this RFI will not
preclude any organization from later being able to submit an
application/proposal. Issuance of this RFI does not constitute a Notice of
Funding Opportunity/Request for Proposal, which is issued through a
separate process. The RFI does not represent any award commitment on the
part of the United States Government, nor does it obligate the Government
to pay for costs incurred in the preparation and submission of any
comments. Information received as part of this RFI shall become the
property of USAID, therefore proprietary information that cannot be shared
should not be sent.

This RFI can be downloaded from 
http://www.grants.gov and http://fbo.gov.

Responses should be submitted to USAID via email to 
IHSIP@usaid.gov 
with a
subject line "RFI-AID-GH-18-MQASSP
 
no later than the date and time indicated on the first page of this 
announcement -- *Jun 20, 2018 5:00 pm EDT US*. 

Please use exclusively the 
IHSIP@usaid.gov   email address 

and please do not respond to this email.

Best regards,

Lisa Ludeman, MSPH
Senior Pharmaceutical Management Advisor
USAID/GH/OHS
eludeman@usaid.gov
<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] USAID: Medicines Quality Assurance Systems Strengthening - Request for Information, Lisa Ludeman <=